Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Troponin T is one of three subunits comprising the troponin complex found in striated muscles—skeletal and cardiac but not smooth muscle. It binds tropomyosin and helps position it on actin filaments within muscle fibers. This positioning enables regulation of muscular contraction by modulating access to myosin-binding sites on actin in response to changes in intracellular calcium concentration. The gene encoding human cardiac Troponin T is TNNT2; there are also slow skeletal (TNNT1) and fast skeletal isoforms (TNNT3). Cardiac-specific Troponin T released into blood serves as an essential clinical marker for diagnosing acute myocardial infarction and assessing prognosis after various forms of heart damage or stress. Mutations in certain isoforms can lead to inherited myopathies or cardiomyopathies due to altered contractile regulation.
Not applicable as a direct drug target; instead, Troponin T serves as a biomarker for cardiac injury. Drugs do not typically target this molecule directly but may influence its release into circulation by causing or preventing myocardial damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Troponin T (TnT).